Publicações

Alternative (Egf114299): A Study of Lapatinib, Trastuzumab, and Endocrine Therapy in Patients Who Received Neo-/Adjuvant Trastuzumab (Iv) and Endocrine Therapy

AuthID
P-005-EWY

Author(s)

Gradishar, WJ

Kahan, Z

Tsang, J

Timcheva, C

Tjulandin, S

Cardoso, F

Grigiene, R

Iwata, H

Keane, M

Luebbe, K

Neskovic Konstantinovic, Z

Simon, SD

Stemmer, S

Vrbanec, D

Arbani, T

Florance, AM

Huang, YJ

Leigh, M

Wroblewski, S

Johnston, SRD

Tipo de Documento

Abstract

Year published

2012

Publicado

in JOURNAL OF CLINICAL ONCOLOGY, ISSN: 0732-183X

Volume: 30, Número: 15

Conference

48Th Annual Meeting of the American-Society-Of-Clinical-Oncology (Asco), Date: JUN 01-06, 2012, Location: Chicago, IL, Patrocinadores: Amer Soc Clin Oncol (ASCO)

Indexing

Wos^®

Metadata
Fontes

Publication Identifiers

Wos: WOS:000318009800318

Source Identifiers

ISSN: 0732-183X

Export Publication Metadata

Lista Marked

Adicionar à lista Marked

Info

At this moment we don't have any links to full text documens.

Alternative (Egf114299): A Study of Lapatinib, Trastuzumab, and Endocrine Therapy in Patients Who Received Neo-/Adjuvant Trastuzumab (Iv) and Endocrine Therapy

Links Úteis

Ajuda

Autenticação Federada (Clique na imagem)

Alternative (Egf114299): A Study of Lapatinib, Trastuzumab, and Endocrine Therapy in Patients Who Received Neo-/Adjuvant Trastuzumab (Iv) and Endocrine Therapy

Links Úteis

Ajuda